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Systemic autoimmune nephritogenic components induce CSF-1 and
TNF-a in MRL kidneys. MRL-Fas" mice are an appealing strain to
understand the importance of eytokines in the pathogenesis of autoim-
mune renal destruction, since injury is rapid and predictable. Colony
stimulating factor 1 (CSF-l) and tumor necrosis factor alpha (TNF-a) are
detected in the kidney and circulation prior to renal injury and continue to
increase with progressive renal damage in MRL-Fas", Fas deficient mice,
hut not the congenic Fas intact MRL-++ strain. Delivery of CSF-1, but
not TNF-a, into the kidney via gene transfer incites local renal injury. By
comparison, dual gene transfer of CSF-l and TNF-a incites autoimmune
renal injury that is far more severe than CSF-I alone. The purpose of this
study was to establish whether CSF-1 and TNF-o expression in the kidney
of MRL-Fas' mice induced by a circulating stimulant resulted from a
primary defect in the kidney. Therefore, we transplanted (Tx) a MRL-+ +
kidney without CSF-1, TNF-a and renal injury into an MRLFash1r
recipient after removing nephritie kidneys expressing CSF-1 and TNF-n.
The Tx kidneys were examined after 2, 4, 5, 6, and 12 weeks. CSF-1 and
TNF-a were rapidly induced in the MRL-+ + Tx kidney. CS F-I and
TNF-a were evident by two weeks and continually increased for i 2 weeks
post-transplantation. Within several weeks, the rapid expansion of M4
and T cells and induction of glomerulonephritis and interstitial nephritis
in the MRL-++ Tx kidney was similar to the age-matched native
MRL-Fas" kidney. In conclusion, we have constructed an experimental
transplantation system that can explore whether cytokine expression in the
kidney induced by a circulating stimulant is a result of a primary defect in
the kidney. Using this approach, we established that the MRL-Fas'
kidney is not defective, but rather a circulating stimulant in the MRL-
FasIPr mouse can induce CSF-1, TNF-a and renal injury in a normal
MRL-++ kidney. Thus, we exclude an intrinsic defect in the MRL-Fas1"
kidney as the pathogenic mechanism responsible for tissue damage. We
suggest purging the circulation of molecules that induce CSF- I and TNF-n
as a therapeutic strategy for autoimmune renal injury.
Although multiple cytokines are evident during kidney destruc-
tion in MRL/MPJ-lpr!lpr (MRL-Fas") mice, only a few are
detected prior to renal injury. We reasoned that eytokines increas-
ing in the kidney prior to injury are responsible for initiating
autoimmune kidney disease. We have previously established that
CSF-I and TNF-a are detected in the kidney and circulation in
MRLFas'P mice, well in advance of renal injury. Furthermore,
CSF-1 and TNF-a increase with progressive renal damage [1, 21.
In addition, vivo gene transfer of genetically modified tubular
epithelial cells delivering CSF-l fostered the influx of macro-
phages (M4) and resulted in glomerular and interstitial nephritis
in MRL-Fas" mice. Although TNF-a alone did not incite renal
injury, dual delivery of CSF-1 and TNF-a increased M4 in the
kidney and renal injury in comparison to CSF-1 alone [3].
Therefore, we suggest that the simultaneous expression of CSF-1
and TNF-a in the kidney of MRL-Fas" mice is pivotal to the
accumulation of M in the kidney and in inciting progressive
renal injury characteristic of this strain.
The requirements for heightened CSF-1 and TNF-a expression
in the kidney are distinctive. The Fas' mutation is required to
up-regulate CSF-1 and TNF-a in the kidney. Congenic strains
without Fas" mutation do not express either cytokine. Therefore,
CSF-1 in the kidney requires the interaction of MRL-background
genes and Fas" mutation [1]. In comparison, the expression of
TNF-cs is more complex. TNF-a up-regulation in MRL-Fas'
mice is linked to two distinct mechanisms: (1) in neonates TNF-a
is associated with the Fas gene; and (2) in mature mice TNF-
correlates with the severity of renal injury.
To determine whether the expression of CSF-1 and TNF-a
resulted from a defect in the MRL-Fas"' kidney, we explored
whether renal expression of either molecule induced by a circu-
lating stimulant in the MRL-Fas" mice could be induced in a
normal kidney. To address this issue, we devised a transplant
strategy that placed a congenic normal donor kidney (MRL-++)
into a syngeneic strain after removing kidneys expressing CSF-1,
TNF-a, and glomerular and interstitial nephritis. CSF-1 and
TNF-u and renal injury, which mimicked the nephrectomized
kidney, were rapidly induced in the donor MRL-+ + Tx kidney.
Thus, we determined that CSF-1 and TNF-a and renal injury
could be induced in a normal kidney Tx into a syngeneic host with
systemic progressive kidney disease. We conclude that the induc-
tion of CSF-1 and TNF-a and in turn, the tempo of injury is
dictated by pathogenic circulating component(s) and does not
result from an intrinsic renal defect.
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METHODS
Mice
Autoimmune MRL-Fas' (H2k) and normal MRL-+ + (H-25)
mice were purchased from The Jackson Laboratory (Bar Harbor,
ME, USA) and were maintained in our animal facility on standard
laboratory chow.
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Reagents
Polyclonal rabbit anti-mouse L cell-derived CSF-1 was provided
by Dr. R. Shadduck (Monteflore Hospital, Pittsburgh, PA, USA),
and polyclonal rabbit anti-human CSF-1 was provided by Genetics
Institute (Cambridge, MA, USA). Rabbit anti-murine TNF-a
antibody is a gift from Dr. A. Cerami (Picower Institute for
Medical Research, Manhasset, NY, USA [4]). Monoclonal anti-
body for F4/80 antigen was obtained from American Tissue
Culture Collection and purified by affinity chromatography of
supernatants over protein A-Sepharose CL-4B columns (Pharma-
cia, Piscataway, NJ, USA). CD4, CD8, and unique T cells (CD4,
CD8, B220), characteristic of MRL-Fas"' mice, referred to as
B220 T cells, were detected by monoclonal antibodies purchased
from PharMingen (San Diego, CA, USA).
Transplanting a normal MRL-++ kidney into a bilaterally
nephrectomized MRL-Fas" mouse
A kidney from a male MRL-+ + mouse 3 to 3.5 months of age
was transplanted into bilaterally nephrectomized age-matched
male MRL-Fas1"° or MRL-+ + mice as previously described [5].
Briefly, animals were anesthetized with isoflurane and the donor
kidney, ureter, and bladder were harvested en bloc, including the
renal artery with a small aortic cuff and the renal vein with a small
caval cuff. These vascular cuffs were anastomosed to the recipient
abdominal aorta and vena cava, respectively, below the level of
the native renal vessels. Total ischemic time averaged 35 to 40
minutes. Donor and recipient bladders were attached dome to
dome. The right native kidney was removed at the time of
transplantation and the left native kidney was removed through a
flank incision four days later.
Evaluation of renal pathology
We examined kidneys removed from the recipient MRLFast"
strain at 2, 4, 5, 6, 12 weeks post-transplant, and compared the
histopathology to the donor MRL-+ + contralateral kidney and
the recipient MRL-Fas' kidney removed at the time of trans-
plantation. Thus, the renal pathology in the MRL-+ + contralat-
eral kidney reflects the histology prior to transplantation and the
pathology of the recipient kidney reflects the severity of disease at
the beginning of the transplantation. Kidney sections for light
microscopic evaluation were fixed with 10% buffered formalin,
paraffin-embedded, and stained with hematoxylin and eosin.
Using a light microscope we counted the cells in intra- and
periglomerular areas of 20 randomly selected glomcruli that were
detailed cells/glomerulus. Interstitial mononuclear cells were
counted in 10 randomly selected fields of cortical interstitium with
a light microscope (x400) and described as cells/field. Perivascu-
lar cell infiltration was evaluated in 10 inter- and intralobular
arteries, and graded by counting the number of cell layers
surrounding the vessel: 0, none; 1, <5 layers surrounding <50%
of the vessel; 2, 5 to 10 layers surrounding >50% of the vessel; 3,
> 10 layers. All slides were analyzed by two individuals using
coded slides, To explore the tempo of renal injury in MRL-+ + Tx
kidney, we evaluated the cell increase (%) in the transplanted
kidney at 2, 4, 5, 6, and 12 weeks above the donor MRL-+ +
kidney. These values were then compared with the cell increase
(%) in the native MRL-Fas kidney above the native MRL-+ +
kidneys (1 to 6 months of age; Fig. 2).
Immunohistochemical examination
Tissue for immunoperoxidase staining were directly snap-fro-
zen in OCT (Miles Scientific, Naperville, IL, USA) and stored at
—80°C. We located M, CD4, CD8, and B220 T cells, character-
istic of MRL-Fas"° mice. These determinants were identified
using the avidin-biotin complex immunoperoxidase technique as
previously described [6]. Glomerular M4, CD4, CD8, and B220 T
cells were graded from 0 to 3 (0, none; 1, mild; 2, moderate; 3,
severe) by counting each cell type in the glomerular, interstitial
and perivascular area. We evaluated the intra- and periglomerular
areas in 20 randomly selected glomeruli. We graded interstitial
M4, CD4, CD8, and B220 T cells in 10 randomly selected fields of
cortical interstitium under a light microscope (X400) from 0 to 3
as above. Similarly, we graded the perivascular Mçb, and T cells in
10 inter- and intralobular renal arteries.
In addition, we detected CSF-1 and TNF-a within the kidney by
immunoperoxidase staining using polyclonal rabbit anti-human
CSF-1 antibody (10 jLg/ml) and rabbit anti-murine TNF-n anti-
body (1:150 dilution). We evaluated CSF-1 in sections (4 rm)
which were cut from frozen blocks and fixed in 95% ethanol for
five minutes using the immunoperoxidase technique. To evaluate
TNF-a, we fixed tissues in 10% phosphate-buffered formalin,
embedded in paraffin and stained for the presence of TNF-a using
the immunoperoxidase technique [2]. The amount and extent of
cytokine was evaluated in at least 50 glomeruli graded from 0 to
3 (0, none; 0.5, trace; 1, mild; 2, moderate; 3, severe)
To determine whether IgG or C3 were expressed, 4 tm frozen
sections were stained with fluorescein isothianate (FITC)-conju-
gated anti-murine IgG and C3 (Cappel Laboratories, Malvern,
PA, USA) at 37°C for 30 minutes. The amount and extent of
fluorescence was evaluated in at least 50 glomeruli graded from 0
to 3.
Eliminating the possibility that surgical complications induce
CSF-1, TNF-a and renal injury
To explore the possibility that surgical complications related to
ischemia and reperfusion induce CSF-1 and TNF-z and renal
injury in the recipient mice, each cytokine and renal injury was
assessed in MRL-+ + donor kidneys (3 to 5 months of age) Tx
into MRL-+ + recipients (3 months of age). We analyzed renal
CSF-l and TNF-a and histology at two and five weeks post-Tx
and assessed CSF-1 in the sera as previously described [7]. Blood
was obtained by cardiac puncture before transplantation and one,
two, five weeks post-transplantation, respectively, for the deter-
mination of circulating CSF-1 by colony stimulating assay in the
transplantation from a MRL-+ + donor to a MRL-± + recipient
and measured as colony forming units (CFU). Blood samples
were allowed to clot at 4°C, centrifuged, and the sera were stored
frozen until use and assayed in duplicate.
Statistical analysis
The data represent the means se and statistical significance
was determined by ANOVA analysis.
REsUL'rs
Transplanting a normal MRL-++ kidney into the MRL-Fast"
recipient induces glomerulonephritis and interstitial nephritis
The cells in the donor MRL-+ + kidney 3 to 3.5 months of age
increased following transplantation into the age-matched MRL-
Fas"' recipient (Fig. 1 A, B, and Table 1). As rapidly as two weeks
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Fig. 1. Transplanted (Tx) kidney into an MRL-Fas" recipient induces
glomerulonephritis. The donor MRL-+ + kidney (3 months of age) prior
to transplantation was normal (A). Tx the MRL-++ kidney into MRL-
Fas" recipient induced an increase of cells within (intra) and surrounding
(pen) glomeruli five weeks post-Tx (B) that was similar to the recipient
MRL-Fas" kidney (3 months of age) at the time of transplantation (C)
(hematoxylin and eosin stain, X500).
post-Tx the cells in the glomerulus, interstitium and perivascular
areas were notably increased as compared to the kidney prior to
the Tx (Fig. 2A and Table 1). The periglomerular area increased
more than the intraglomerular area, and by five weeks post-Tx was
similar to the nephrectomized recipient (Fig. 1 B, C, and Table 1).
For example, in the MRL-+ + Tx kidney the cells increased from
43 3 to 54 2 in the intraglomerular area and from 14 2 to
38 2 in the periglomerular area. This was similar to the
intraglomerular (54 3) and perivascular (34 2) cells in the
recipient kidney at the time of transplantation. There was a
parallel increase in the interstitial and perivascular areas in the
MRL-+ + Tx kidney that reached values noted in the recipient's
nephrectomized kidney (Fig. 2A and Table 1). The cells in the
glomerulus, interstitium and perivascular area continually in-
creased and were maximal at 12 weeks post-transplantation. The
number of cells in the Tx kidney within intraglomerular, periglo-
merular, interstitial and perivascular lesions was higher than in
the contralateral MRL- + + kidney that was not Tx, and nearly
equal to the recipient MRL-Fas" kidney removed at the time of
transplantation (Table 1).
Rapid progression of glomerulonephritis and interstitial
nephritis in the MRL-++ transplanted kidney
To explore the tempo of renal injuly, we compared the pro-
gression the cell increase (2, 4, 5, 6, 12 weeks) in the transplan-
tation with the native MRL-Fas" renal disease (Fig. 2). The
tempo of the cell expansion in the MRL- + + kidney Tx into the
MRL-Fas' mouse at three months of age was rapid (Fig. 2A).
The cells increased in the glomerulus by two weeks post-Tx (Fig.
2A) and reached levels by 12 weeks that required five months in
the native MRL-Fas" kidney (Fig. 2B). The cell numbers in the
Tx kidney (Fig. 2A) rose rapidly by six weeks; for example, the
number of the perivascular cells were as great as those in the
native MRL-Fas" mice three months of age (Fig. 2B). In
addition, the cell increase in the interstitium in the Tx MRL-+ +
kidney at 12 weeks post-transplantation matched the level noted
in the native MRL-Fas'' kidney at six months of age (Fig. 2B). It
should be noted that in MRL-+ + mice three to six months of age
the number of cells in the glomerulus, interstitium and perivas-
cular area remain constant (Table 1).
Macrophages and T cells increase in MRL- + + transplanted
kidney post-transplantation
We determined whether the cell increase in the transplantation
consisted of M4 and T cells. M were prominent in the glomeruli
and interstitium of the MRL-+ + kidney Tx into MRL-Fas
mice. The increase in Mq' and T cells began two weeks post-Tx in
the glomerular, interstitial and perivascular lesion of MRL-+ +
Tx kidney and continually increased for 12 weeks (Table 2). B220
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Table 1. Transplanting an MRL-+ + kidney into A MRLFash1C recipient results in an increase in glomerular, interstitial and perivascular cells
Strain
Tx Donor Recipient Age N
Intraglom Periglom . .Interstitial
Cells/fl eld5
.Perivascular
Grades of infiltrates'Cells/glom'
Weeks
MRL-++ MRL-Fas" 2—12 5 54 _l 37 4" 96 18" 1.8 0.2"
MRL-++ MRL-++ 2
5
2
5
43 3
44±3
14 2
16±3
27 6
25±3
0.4 0.2
0.4±0.2
MRL-+ + none 6 42 1 16 1 27 2 0.4 0.2
none MRL-Fas" 5 54 3 34 2 76 9 2.2 0,4
Native Months
MRL-Fas" 1
2
3
4
5
6
2
2
5
4
2
2
34 1
45±4
54±356 2
58±3
58±3
15 2
16±2
34±236 2
58±6
65±5
43 5
75±6
76±9
80 10
119±16
155±24
0 0
0.7±0.2
2.2±0.4
2.1 0.3
2.2±0.3
2.6±0.3
MRL-++ 3
4
6
6
4
2
43 3
42±2
41±3
14 2
18±2
16±2
27 6
22±2
20±3
0.4 0.2
0.4±0.2
0.5±0.3
Abbreviations are: Tx, transplantation; glom, glomerulus. Values are mean SE.
Intra- and periglomerular cells were counted in randomly selected 20 glomeruli (X400)
Mononuclear infiltrates in cortical interstitium were counted in 10 randomly selected fields (X400)
Perivascular infiltrates were evaluated in randomly selected 10 inter- and intralobular arteries (x400) and graded as follows: 0, none; 1, <5 layers
surrounding <1/2 circle of the vessels; 2, 5—10 layers surrounding >1/2 circle of the vessels; 3, >10 layers surrounding the vessels.
P < 0.05 vs. donor MRL- + + kidney
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Fig. 2. The cell increase in the glomeruli (periglomerular, A), interstitium (C)) and perivascular (•) areas in the MRL- + + kidney transplanted (Tx)
into the MRL-Fas" strain. The number of periglomerular, interstitial and perivascular cells began to increase two weeks post-Tx and continued to
increase for 12 weeks in MRL-++ Tx kidney. The cell increase in MRL-++ Tx kidney above the donor MRL-++ kidney was evaluated, (A). Note
the cell increase in each component in the native MRL-Fas' kidney during its natural progression (B).
and CD4 T cells were most notably detected, while CD8 cells were 3). The pattern of TgG and C3 in the Tx MRL-+ + kidneywas similar
rare. This phenotypic profile was similar in the native MRL-Fas'' to the deposition of IgG and C3 in the native MRLFash1r kidney.
kidney. lgG and C3 deposits were in the glomerular mesangium and less
prominent in the interstitium and perivascular areas. The deposition
IgG and C3 are detected in the MRL- + + transplanted kidney of IgG and C3 was more rapid in the MRL- + + kidneys two to six
We evaluated the deposition of lgG and C3 in MRL-+ + kidney weeks post-transplantation, than in the native MRLFash1ar kidney
Tx into MRLFa,smPr mice up to six weeks post-transplantation (Table evaluated between one to six months (Table 3).
1 2 3 4 5 6
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Table 2. Macrophages and T cells are responsible for the cell increase in the MRL-+ + kidney transplanted into MRL-Fas" recipient
Strain Age months
Glomerular (intra + pen) Interstitial/perivascular
F4/80 CD4 CD8 B220 F4/80 CD4 CD8 B220
Tx weeks
2
4
5
6
12
3.5
3.5
3
3
3
1
1
2
3
3
0
—
1
—
—
0
—
0
—
1
1
1
2
2
1/1
1/1
2/2
2/2
3/3
0/0
—
1/1
—
—
0/0
—
0/0
—
—
0/1
0/1
0/1
1/2
2/2
Native
MRL-Fas" 1
2
3
4
6
0
1
2
3
3
0
1
2
2
3
0
1
1
1
1
0
0
1
2
2
0/0
1/1
1/1
2/2
3/3
0/0
1/1
1/1
2/1
3/2
0/0
1/1
1/1
1/1
1/2
0/0
1/1
1/1
1/2
2/3
MRL-++ 3
4
6
0
0
0
0
0
0
0
0
0
0
0
0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
F4/80 (macrophage) and B220 (double negative T cell) were stained by immunoperoxidase method using mAb for each antigen. Intensity of the
staining was graded from 0 (none) to 3 (maximum). Abbreviations are: Tx, transplantation; —, not determined.
Table 3. IgG and C3 in the donor MRL-+ + kidney could be detected
as rapidly as 2 weeks post-transplantation into the MRL-Fas'' recipient
and continued to increase
Interstitial/
Strain Age months
Glom
IgG
erular
C3
perivascular
IgG C3
Tx weeks
2 3.5 2 1 1/1 1/1
4 3.5 2 — 1/1 —
5 3 3 2 1/1 1/1
6 3 3 — 2/2 —
Native
MRLFas/jr 1
2
3
4
6
1
1
2
3
1
1
2
3
— —
0/1 0/1
1/1 1/1
1/1 1/1
2/2 2/2
MRL-++ 3
4
6
1
1
1
0
0
0
0/0 0/0
0/0 0/0
0/0 0/0
IgG and C3 were stained by immunofluorescence method using Ab for
each antigen. Abbreviations are: Tx, transplantation; —, not determined.
Intensity of the staining was graded from 0 (none) to 3 (maximum).
A circulating stimulant in the recipient MRL-Fas1" mouse
induces CSF-1 and TNF-a in the transplanted MRL-++
kidney
CSF-1 and TNF-a were rapidly induced in the donor MRL-+ +
kidney Tx into an age-matched MRL-Fas recipient (Table 4). In
the MRL-+ + Tx kidney, CSF-1 was detected mainly in glomeruli
and less in the interstitium and perivascular areas two weeks
post-transplant (grades 2, 1 and 1, respectively; Table 4). CSF-1 in
the MRL-+ + Tx kidney continued to increase, and by four to five
weeks post-transplantation the level of CSF-1 was similar to the
amount in glomerular, interstitial and perivascular areas in the
MRL-Fas" recipient kidney removed at the time of transplanta-
tion (grades 3, 1, and 1, respectively, Fig. 3 B, C, and Table 4).
CSF-1 continued to increase in the donor kidney and by 12 weeks
post-transplant it was similar to that of the native MRL-Fad"
kidney six months of age (Table 4).
Although TNF-a was also induced in the MRL-+ + kidney Tx
into the MRLFaslr strain, the location differed from CSF-1
(Table 4). TNF-a was detected mainly in tubuli and perivascular
lesions (perivascular infiltrates and vascular smooth muscle) and
was less prominent in glomeruli (Fig. 4B and Table 4). TNF-c was
rapidly induced and after four weeks post-transplant and the
intensity and distribution of TNF-s in the MRL-+ + Tx kidney
was similar to the MRL-Fas" kidney expressed at the time of
transplantation (Fig. 4C and Table 4). It should be noted that
CSF-1 and TNF-cs were not detectable in the donor MRL-+ +
kidney prior to being Tx into the MRL-Fas1" recipient (Figs. 3A
and 4A; Table 4).
Surgical complications do not induce CSF-1, TNF-o nor renal
injury in the transplanted MRL-++ kidney
To eliminate the possibility that the surgical complications
possibly related to isehemia and reperfusion induced the expres-
sion of CSF-1 and TNF-s, and promoted renal injury, we Tx a
MRL-++ kidney into a bilaterally nephrectomized MRL-++
recipient. No cell change was detected in the glomerulus, inter-
stitium or perivascular area two and five weeks post-transplanta-
tion (Table 1). In addition, in contrast to the induction of CSF-1
and TNF-cx in the MRL-++ kidneys Tx into the MRL-Fas
recipients, CSF-1 and TNF-cs were not induced in MRL-+ +
kidneys Tx into MRL-+ + recipients two and five weeks post-
transplantation (Table 4). Furthermore, we did not detect an
increase in circulating CSF-1 in the MRL-+ + kidney Tx into the
MRL-+ + mouse. The level of CSF-1 pre-Tx (0 0 CFU, N =3),
at one week post-transplant (0.5 0.9 CFU, N = 3), two weeks
post-transplant (0.5 CFU, N = 1) and five weeks post-transplant
(0 0 CFU, N = 2) were similar. Since the level of circulating
CSF-1 reflects the amounts of CSF-1 in the kidney [8j, this further
suggests that surgical complications did not incite an increase in
circulating cytokines.
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Table 4. CSF-1 and TNF-n is induced in the donor MRL-++ kidney
transplanted into a recipient MRL-Fas' strain
Strain
Age
-_Glom
CSF-i
Interstitial!
erular perivascular
TNF-a CSF-1 TNF-aTx Donor Recipient
MRL-++
MRL-++
MRL-++
none
.Native
MRLFash1r
MRL-Fas'
MRL-++
none
MRL-Fas"
Weeks
2
4
5
6
12
2
5
Months
1
2
3
4
6
2
—
3
3
3
0
0
0
2
0
1
2
3
3
1 1/1 1/1
1 1/i 2/2
2 1/1 2/2
2 1/1 3/32/2 —
0.5 0/0 0.5/0.5
0.5 0/0 05/0.5
0.5 0/0 0.5/0.5
1 1/1 2/2
1 0/0 1/1
1 0/1 1/1
1 1/1 2/2
2 1/1 2/2
3 2/2 3/3
MRL-++ 3
4
6
0
0
0
0.5 0/0 0.5/0.5
1 0/0 1/1
1 0/0 2/1
CSF-1 and TNF-a were stained by immunoperoxidase method using Ab
for each antigen. Abbreviations are Tx, transplantation; —, not deter-
mined. Grades are: 0 = none; 0.5 = trace, I = mild, 2 = moderate, 3 =
severe.
DISCUSSION
We have established a renal transplant system to explore
whether CSF-1 and TNF-a in the MRL-Fas" kidney is induced
by a circulating stimulant and requires an intrinsic renal defect.
We transplanted (Tx) the kidney of a congenic MRL- + + mouse
without CSF-1, TNF-a and renal injury into a MRL-Fas" after
removing the nephritic kidneys expressing colony stimulating
factor (CSF-1) and tumor necrosis factor alpha (TNF-a). Using
this system, we established that the MRL-Fas' kidney does not
have an intrinsic defect, but rather a circulating stimulant in the
MRL-Fas' mouse can induce CSF-1, TNF-a and renal injury in
normal MRL- + + kidneys.
The expression of CSF-1 and TNF-cs and renal injury could not
be noted in the MRL-+ + kidney Tx into a MRL-+ + recipient in
short- and long-term experiments (2 and 5weeks post-transplant).
These data suggest that surgical complications related to ischemia
and reperfusion did not induce CSF-1 or TN F-a in MRL-+ +
mice. Nevertheless, it is possible that ischemia related to the
surgical procedure may alter the level of the expression of each
cytokine and the tempo of renal injury in MRL-Fas" mice.
There are many components including circulating molecules
and cells identified in the serum of MRL-Fas', hut not in the
congenic MRL-+ + strain, which could be responsible for induc-
ing CSF-1, TNF-a and renal injury. The induction of CSF-1 and
TN F-a and renal injury could result from a molecule either in the
circulation or released by infiltrating cells, a consequence of the
Fas deficiency and failure to delete autoreactive cells. Plausible
systemic candidates in the MRL-Fas" mice include TNF-a and
IL-i [2]. TNF-a stimulates both TNF-a and CSF-1 production by
monocytes and mesangial cells [6, 9, 10]. In support of this
concept, we previously reported an increase of TNF-a both in the
circulation and in the kidney in MRL-Fas1' mice that was
Fig. 3. Colony stimulating factor 1 (CSF-1) is induced in the MRL-++
kidney transplanted (Tx) into the MRL-Fas" recipient. CSF-1 was not
detected in the donor MRL-+-+ contralateral kidney three months of age
1A). CSF-1 was induced in the glomeruli in the MRL-++ kidney Tx into
the MRL-Fas'' strain five weeks post-transplantation (B). The distribu-
tion of CSF- I in MRL-+ + Tx kidney was similar to that of recipient
MRI,-Fas" mice at the time of transplantation (C) (immunoperoxidase
staining, X500).
detected prior to renal injury and was proportional to the severity
of lupus nephritis [2]. On the other hand, IL-i may be responsible
for inducing TNF-a, since MRL-Fas mice have a fundamental
regulatory defect in IL-I and are abundant in the kidney. Thus, it
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are a source of CSF-1 [12] and TNF-a [10]. Secondly, CD4 T cells
secrete Th2 cytokines that provide signals to B cells to produce
IgG, and in turn IgG aggregates stimulate mesangial cells to
generate CSF-1 and TNF-cs [13—161. Since B cells in the MRL-
Fash1r strain produce an excessive amount of IgG, circulating IgG
could be responsible for inducing CSF-1 in MRLFash1r kidneys
[17]. In support of this concept, B cell-deficient "knockout"
MRL-Fas" mice do not develop autoimmune kidney destruction
[18]. It is interesting to note that we simultaneously detected
CSF-1 and IgG in MRL-+ + kidney Tx into MRL-Fas" mice.
Finally, CD4 T cells are required for CSF-1, TNF-a and renal
injury. This is based on the findings that MRL-Fas' mice
deficient in major histocompatibility complex (MHC) class 11(a)
lack CD4 T cells and do not develop renal disease [19], and (b)
CD4 T cell-deficient "knockout" MRL-Fas" mice do not express
CSF-1 or TNF-cx in the kidney and are protected from renal injury
(preliminary data). Taken together, autoreactive CD4 T cells in
the MRL-Fas' recipient and their interaction with B cells may be
responsible for initiating CSF-l and TNF-cs and renal injury in the
MRL-+ + Tx kidney.
Based on our findings, we would predict that purging the
circulation of molecules that induce CSF-1 and TNF-a and renal
injury in humans should resolve autoimmune renal destruction. In
a reciprocal experiment, we Tx a nephritic MRLFaslPr kidney
with CSF-1 and TNF-a and renal injury into a congenic MRL-+ +
mouse with normal kidneys lacking CSF-1 and TNF-cs. In the
absence of a circulating stimulant(s) in the MRL-Fas' mouse,
CSF-1 and TNF-a disappeared and renal injury resolved [8]. This
reciprocal experiment establishes that a continual circulating
stimulant in MRL-Fas° mice is required to maintain CSF-1,
TNF-cs expression, and promote renal injury. A critical issue
remains: what is the point of no return, that is, the level of renal
injury that cannot be exceeded, for the rescue to be successful?
Nevertheless, our data indicate that removing circulating stimu-
lant(s) that induces CSF-1 and TNF-a should offer a therapeutic
approach for autoimmune kidney disease.
In summary, we have established an experimental transplanta-
tion system that can explore whether cytokine expression in the
kidney is a result of a primary intrinsic defect in the kidney and is
induced by a circulating stimulant. Using this approach, we
establish that CSF-1 and TNF-a and renal injury in the MRL-
Fas1" kidney is induced by a circulating stimulant. Most impor-
tantly, we can exclude an intrinsic defect in the MRL-Fas1" kidney
as the pathogenic mechanism required for tissue damage.
ACKNOWLEDGMENTS
Fig. 4. TNF-a is induced in the MRL-+ + kidney transplanted (Tx) into This work was supported by National Institutes of Health DK 36149
the MRL-Fas" recipient. TNF-n could be barely detected in the donor (VRK) and the Baxter Extramural Grant Program (VRK). TW is a
MRL-+ + contralateral kidney (A). By comparison, TNF-a was induced in recipient of Japan Society of Promotion of Science.
the donor kidney Tx into the MRL-Fas'° recipient five weeks post-Tx in
tuhuli and vessels and in lesser amounts in glomeruli (B). TNF-a was
detected in the recipient MRL-Fas kidney at the time of Tx (C) Reprint requests to Vicki Rubin Kelley, P/rD., Laboratoiy of Immunoge-(immunoperoxidase staining, x500). netics and Transplantation, Renal Division, Brigham and Women's Hospital,
75 Francis Street, Boston, Massachusetts 02115, USA.
is also possible that IL-I induces TNF-a, which in turn induces APPENDIXCSF-1 [11]. Clearly, the exact sequence of this "billiard" effect
remains to be unraveled. Abbreviations used in this paper are: CSF-l, colony stimulating factor 1;
Autoreactive CD4 T cells in the MRL-Fas" recipient may be TNF-a, tumor necrosis factor alpha; Tx, transplanted; M4, macrophages;
responsible for inducing CSF-1 and TNF-. Firstly, CD4 T cells CFU, colony forming unit.
Wada et a!: Systemic component induces CSF-1 and TNF-a 941
REFERENCES
1. Yui MA, BRISSEYFE WH, BRENNAN DC, WUTHRICI-I RP, KELLEY VE:
Increased macrophage colony-stimulating factor in neonatal and adult
autoimmune MRL-Ipr mice. Am J Pathol 139:255-261, 1991
2. YOKOYAMA H, KREFr B, KELLEY VR: Biphasic increase in circulating
and renal TNF-a in MRL-lpr mice with differing regulatory mecha-
nisms. Kidney mt 47:122—130, 1995
3. MooRE KJ, YEH K, NAIT0 T, KELLEY VR: TNF-a enhances colony-
stimulating factor-i-induced macrophage accumulation in autoim-
mune renal disease. J Immunol 157:427—432, 1996
4. BEUTLER B, MILSAItK 1W, CERAMI AC: Passive immunization against
cachectin/tumor necrosis factor protects mice from lethal effect of
endotoxin. Science 229:869— 871, 1985
5. NvsBrrr T, COFFMAN TM, GRIFFITHS R, DREZNER MK: Crosstrans-
plantation of kidneys in normal and Hyp mice. Evidence that the Hyp
mouse phenotype is unrelated to an intrinsic renal defect. J Clin In vest
89:1453—1459, i992
6. BRENNAN DC, JEVNIKAR AM, BLOOM RD, BRISSECrE WH, SINGER
GG, KELLEY VE: Cultured mesangial cells from autoimmune MRL-
lpr mice have decreased secreted and surface M-CSF. Kidney mt
42:279—284, 1992
7. BRADLEY TR, METCALF D: The growth of mouse bone marrow cells in
vitro. Aust J Exp Biol Med 44:287—299, 1966
8. NAITO T, GRIFFITHS RC, COFFMAN TM, KELLEY VR: Transplant
approach establishes that kidneys are responsible for serum CSF- I but
require a stimulus in MRL-lpr mice. Kidney mt 49:67—74, 1996
9. OSTER W, LINDEMANN A, HORN S, MERTELSMANN R, HERRMANN F:
Tumor necrosis factor (TNF)-u but not TNF-p induces secretion of
colony stimulating factor for macrophages (CSF-1) by human mono-
cytes. Blood 70:1700—1703, 1987
10. SATRIANO JA, HORA K, SI-IAN Z, STANLEY ER, MORI T, SCHLONDORFF
D: Regulation of monocyte chemoattractant protein-i and macro-
phage colony-stimulating factor-I by IFN-y, tumor necrosis factor-u,
IgG aggregates, and cAMP in mouse mesangial cells. J Jmmunol
50:1971—1978, 1993
11. BOSWELL JM, YuI M, BURT DW, KELLEY VE: Increased tumor
necrosis factor and interleukin-i beta gene expression in the kidneys
of mice with lupus nephritis. J Immunol 141:3050—3054, 1988
12. ORME TM, ROBERTS AD, GRIFFIN JP, ABRAMS JS: Cytokine secretion
by CD4 T lymphocytes acquired in response to Mycobacterium
tuberculosis infection, J Immunol 151:518—525, 1993
13. SEDER RA, PAUL WE: Acquisition of lymphokine-producing pheno-
type by CD4+ T cells. Annu Rev Immunol 12:635—673, 1994
14. HORA K, SATRIANO JA, SANTIAGO A, Mom T, STANLEY ER, SI-IAN Z,
SCHLONDORFF D: Receptors for IgG complexes activate synthesis of
monocyte chemoattractant peptide 1 and colony-stimulating factor 1.
Proc NatlAcad Sci USA 89:1745—1749, 1992
15. MULLIGAN MS, VAPORCIYAN AA, MIYASAKA M, TAMATANI T, WARD
PA: Tumor necrosis factor alpha regulates in vivo intrapulmonary
expression of ICAM-1. Am J Pathol 142:1739—1749, 1993
16. GOMEZ-GUERRERO C, GONZALEZ E, HERNANDO P, RUIZ-ORTEGA M,
EGID0 J: Interaction of mesangial cells with IgA and IgG immune
complexes: A possible mechanism of glomerular injury in IgA ne-
phropathy. Contrib Nephrol 104:127—137, 1993
17. THEOPI-IILOPOULOS AN, DIXON FJ: Murine models of systemic lupus
erythematosus. Adv Immunol 37:269—390, 1985
18. SCI1LOMCHIK MJ, MADAIO MP, Ni D, TROUNSTEIN M, HUSZAR D: The
role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 180:1295—
1306, 1994
19. JENIKAR AM, GRUSBY Mi, GLIMCHER LH: Prevention of nephritis in
major histocompatibility complex class It-deficient MRL-lpr mice. J
Exp Med 179:1137—1143, 1994
